Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Tirzepatide for Sale > SMO Top quality 99% Purity Lyophilized Powder tirzepatide 20mg in Stock
SMO  Top quality 99% Purity Lyophilized Powder tirzepatide 20mg in Stock buy - large image1
SMO  Top quality 99% Purity Lyophilized Powder tirzepatide 20mg in Stock buy - image1
SMO  Top quality 99% Purity Lyophilized Powder tirzepatide 20mg in Stock buy - image2
SMO  Top quality 99% Purity Lyophilized Powder tirzepatide 20mg in Stock buy - image3
SMO  Top quality 99% Purity Lyophilized Powder tirzepatide 20mg in Stock buy - image4
SMO  Top quality 99% Purity Lyophilized Powder tirzepatide 20mg in Stock buy - image5
SMO  Top quality 99% Purity Lyophilized Powder tirzepatide 20mg in Stock buy - image6

SMO Top quality 99% Purity Lyophilized Powder tirzepatide 20mg in Stock

TDS 2047 Inquiries

Unit Price:

$35/UNIT FOB

Get Latest Price
CAS No.:

2023788-19-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Hong Kong

Brand:

Novio

Packaging:

20mg/vial,10vials/box

Price valid (until):

2026-09-06

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Peptides,Cosmetic Raw Materials,Pharmaceutical Intermediates

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  




    Sales manager:callie
    whatsapp:+852 46277864
    Email:calliegarrett33@gmail.com

    Product Details Page

    Telapatide – High-Purity Research Peptide (HPLC Purity ≥99%)

    1. Product Overview

    Telapatide (Research Code: LY3298176) is a novel synthetic peptide that simultaneously targets the GIP and GLP-1 receptors. CAS No. 2023788-19-2, Molecular Formula:

    C 225

    H 348

    N 48

    O 68

    Molecular Weight: 4813.53 Da. As a landmark dipeptide drug, it has become a core research material for many laboratories worldwide focusing on metabolic disorders, glucose regulation, and lipid metabolism mechanisms.

    We supply high-quality telapatide lyophilized powder with HPLC purity ≥99.0%. Our raw peptides are produced using standardized peptide synthesis processes and rigorously purified by preparative high-performance liquid chromatography. Each batch undergoes comprehensive analysis and testing to ensure stable quality, suitable for academic research, preliminary drug development, and preclinical laboratory trials.

    Important Note: All telapatide products are for laboratory research use only. This product must not be used for human injection, clinical treatment, as a food additive, or as a veterinary drug. It does not imply any medical effect on humans.



    2.Basic Product Information

    Items Specifications
    Product Name  Tirzepatide
    Synonym  TR  LY3298176, GIP/GLP-1 RA, TZP
    CAS Number  2023788-19-2
    Molecular Formula  C₂₂₅H₃₄₈N₄₈O₆₈
    Appearance White or off-white lyophilized powder
    Purity (HPLC)  ≥99.0%
    Total Related Impurities  ≤1.00%
    Bacterial Endotoxin ≤10 EU/mg
    Solubility  Soluble in purified water & dilute acetic acid
    Storage Condition Store at -20℃, tightly sealed, protect from light
    Unopened shelf life 24 months
    Important Note This product is for laboratory research use only.

    3. Core Advantages of Tizepatide

    Industry-Leading Purity ≥99% HPLC

    Our finished peptides achieve a purity of at least 99.0% for their main components. Single unknown impurities are controlled below 0.50%, and total relevant impurities are ≤1.00%. This low impurity background ensures the reliability and reproducibility of experimental data, avoiding interference with cell experiments and animal model studies.

    Complete Batch Testing Documentation

    Each batch comes with a complete Certificate of Analysis (COA), including HPLC chromatograms, mass spectrometry identification reports, moisture detection, heavy metal detection, and endotoxin detection. All testing standards comply with ICH guidelines, meeting the documentation requirements of overseas university laboratories and biotechnology R&D companies.

    Chemically Stable with a Long Shelf Life

    The freeze-drying process effectively prevents peptide degradation. Under recommended -20°C sealed storage conditions, the product maintains stable chemical properties over a long period. Strict production and drying processes reduce residual moisture to ≤5.0%, thereby slowing down peptide chain hydrolysis.

    Flexible Packaging and Customization Services

    Supports multiple packaging sizes: 5mg, 10mg, 20mg, 30mg, 40mg, 50mg, 100mg. Standard packaging uses inert gas-filled vials. We provide customized private labeling and special packaging solutions for long-term bulk clients.

    Professional Global Logistics Support

    We offer flexible shipping options. For high-value peptide raw materials, we provide cryogenic cold chain transportation solutions to avoid damage caused by high temperatures during international transport. Protective shockproof packaging reduces the risk of loss during long-distance sea or air freight.

    4. Complete Quality Specifications

    Identification (HPLC): Retention time consistent with reference standard

    Identification (MS): Mass spectrum consistent with theoretical molecular weight

    Purity (HPLC): ≥99.0%

    Single unknown impurity: ≤0.50%

    Total relevant impurities: ≤1.00%

    Moisture content (Karl Fischer method): ≤5.0%

    Heavy metals (Pb, As, Cd, Hg): ≤10 ppm

    Residual organic solvents: Compliant with ICH Q3C limits

    Bacterial endotoxins: ≤10 EU/mg

    Amino acid analysis: Consistent with theoretical sequence

    5. Research Applications

    Tizolatide API is widely used in global basic pharmacology research projects:

    GIP and GLP-1 dual receptor signaling pathway mechanism studies

    Preclinical studies of glucose homeostasis and insulin secretion regulation

    Basic research on energy metabolism, appetite control, and adipose tissue metabolism

    Experimental studies in animal models of type 2 diabetes and obesity

    Preliminary drug screening and comparative compound structure studies



    Shop SMO  Top quality 99% Purity Lyophilized Powder tirzepatide 20mg in Stock-Detailed Image 1

    Shop SMO  Top quality 99% Purity Lyophilized Powder tirzepatide 20mg in Stock-Detailed Image 2

    Tirzepatide has been shown to help lose weight in overweight patients. Phase 3 clinical trials are currently underway for weight loss in adults who are overweight, obese, or have weight-related health issues. Tirzepatide has received FDA Fast Track designation to speed up its FDA application for treating adults with obesity, or who are overweight with weight-related health conditions.
    In the SURMOUNT-1 clinical trial, the average weight loss with tirzepatide after 72 weeks was 15% for the 5mg dose, 19.5% for the 10mg dose, and 20.9% for the 15mg dose.

    tirzepatide is a once-weekly glucose-dependent-stimulating polypeptide (GIP, aka: gastric inhibitory polypeptide) receptor and glucagon-like peptide-1 (GLP-1) receptor dual agonist developed by scientists. ChemicalbookGIP and GLP-1 are both hormones secreted by the gut that promote secretion. tirzepatide combines the effects of two -promoting drugs into a single molecule and represents a new class of drugs for the treatment of type 2 diabetes.

    How much weight can you lose in a week with tirzepatide?
    Clinical trials have shown that study participants taking a weekly dose of semaglutide had an average reduction in body weight of 5-10 percent.

    Description:

    Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that is being developed for the treatment of type 2 diabetes. Tirzepatide (LY3298176) shows significantly better efficacy with regard to glucose control and weight loss than do Dulaglutide.

    Tirzepatide, also known as LY 3298176, is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Tirzepatide has a greater affinity to GIP receptors than to GLP-1 receptors, and this dual agonist behavior has been shown to produce greater reductions of hyperglycemia compared to a selective GLP-1 receptor agonist. Signaling studies reported that tirzepatide mimics the actions of natural GIP at the GIP receptor. Tirzepatide was approved for improving blood sugar control in adults with type 2 diabetes, as an addition to diet and exercise.

    Shop SMO  Top quality 99% Purity Lyophilized Powder tirzepatide 20mg in Stock-Detailed Image 3 Shop SMO  Top quality 99% Purity Lyophilized Powder tirzepatide 20mg in Stock-Detailed Image 4 Shop SMO  Top quality 99% Purity Lyophilized Powder tirzepatide 20mg in Stock-Detailed Image 5

    

    Before and after weight loss

    Shop SMO  Top quality 99% Purity Lyophilized Powder tirzepatide 20mg in Stock-Detailed Image 6

    Factory photos
    Shop SMO  Top quality 99% Purity Lyophilized Powder tirzepatide 20mg in Stock-Detailed Image 7 Shop SMO  Top quality 99% Purity Lyophilized Powder tirzepatide 20mg in Stock-Detailed Image 8 Shop SMO  Top quality 99% Purity Lyophilized Powder tirzepatide 20mg in Stock-Detailed Image 9 Shop SMO  Top quality 99% Purity Lyophilized Powder tirzepatide 20mg in Stock-Detailed Image 10

    ECHEMI Editorial Reference

    Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.

    Certificates
    • SMO  Top quality 99% Purity Lyophilized Powder tirzepatide 20mg in Stock Certificates 1 TDS

    Basic Info
    Product Name:

    Tirzepatide

    Other Name:

    LY3298176;

    CAS No.:

    2023788-19-2

    Molecular Formula:

    C225H348N48O68

    Molecular Weight:

    4813

    EC Number:

    200-001-8

    Characteristics
    Appearance:

    White to off-white

    Research
    Class:

    Dual agonist — GIPR, GLP-1R

    Status:

    FDA-approved (Mounjaro / Zepbound)

    Mechanism:

    Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

    EC50 (Human GLP1R):

    0.934 nM

    EC50 (Human GIPR):

    0.0224 nM

    Source:

    Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

    FDA:

    Mounjaro, Zepbound (approved 2022-05-13)

    References
    ChEMBL:

    CHEMBL4297839

    DrugBank:

    DB15171

    KEGG DRUG:

    D11360

    PubChem:

    PubChem

    Disclaimer:

    Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Peptides,Cosmetic Raw Materials,Pharmaceutical Intermediates

    Location:

    Room 1359, Room 103, Building Jia 19, Jixiang Garden, Tongzhou District, Beijing

    Year of Establishment:

    2026

  • Inquiry History
    2047 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    2023788-19-2 in unlabeled vials 10, 15 and 30 mg

    10  Feb 14, 2024
    United States

    Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss 399 Inquiries

    10 MG Apr 3, 2024
    United States

    Tirzepatide Raw Powder Weight Loss Peptides CAS No 2023788-19-2 Tirzepatide Injection Peptides

    2 MT Dec 13, 2025
    Hongkong, China

    2023788-19-2

    1 KG Aug 13, 2026
    Germany

    2023788-19-2

    1 MG Jun 18, 2026
    United States

    2023788-19-2 Retatrutide

    1 G Sep 22, 2023
    United States

    2023788-19-2 Trizepatide

    10 MT Oct 29, 2023
    United States

    Tirzepatide 2023788-19-2

    Feb 19, 2024
    United States

    Tirzepatide 2023788-19-2

    10 G Oct 31, 2023
    United States

    Trizepatide 2023788-19-2 Raw Material LY3298176 Tirzepatide powder

    Dec 2, 2025
    United States

    Fat Burning Peptides Tirzepatide 10mg/Vial 15mg/Vial Tirzepatide CAS: 2023788-19-2

    1 MT Jan 25, 2024
    United States

    Pharmacy Grade CAS 2023788-19-2 Tirzepatide 99% White powder Tirzepatide

    1 MT Oct 20, 2023
    United States

    Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss

    2 KG Oct 20, 2023
    United States

    supply Tirzepatide Safe Material Shipping Trizepatide 2023788-19-2 Raw Tirzepatide powder

    10 MG Apr 4, 2024
    United States

    COA Offer Top quality Weight Loss Peptides Tirzepatide 10mg/vial GLP-1 2023788-19-2

    1 MT Sep 10, 2023
    Kenya

    Janoshik Test Tirzepatide 99% White powder High Quality Tirzepatide Weight loss CAS 2023788-19-2

    30 MG Dec 26, 2025
    United States

    Ex-factory price tirzepatide T30 10vials 30mg kit cas 2023788-19-2 for weight loss peptide

    10  Dec 30, 2024
    United Kingdom

    Manufacturer supply high quality hot sale lowest price Tirzepatide CAS NO,2023788-19-2 99% powder 2023788-19-2 Claire

    100 G Nov 4, 2023
    Canada

    99.9% Purity GLP-1 Injection Weight Loss Peptides Liraglutide Retatrutide Tirzepatide Semaglutide 5mg 10mg CAS 2023788-19-2

    2 MT Oct 22, 2023
    United Kingdom

    tirzepatide

    10 MG Oct 21, 2025
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.